We are live on ! Find out more
CYTK icon

Cytokinetics

134 hedge funds and large institutions have $315M invested in Cytokinetics in 2017 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 43 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 21

2% more funds holding

Funds holding: 132134 (+2)

7% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 46

2.32% less ownership

Funds ownership: 73.92%71.59% (-2.3%)

38% less call options, than puts

Call options by funds: $1.24M | Put options by funds: $1.99M

45% less capital invested

Capital invested by funds: $575M → $315M (-$261M)

Holders
134
Holders Change
+2
Holders Change %
+1.52%
% of All Funds
3.04%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
43
Reduced
46
Closed
21
Calls
$1.24M
Puts
$1.99M
Net Calls
-$754K
Net Calls Change
-$3.51M
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
76
Millennium Management
New York
$218K +$303K +26,730 New
State Board of Administration of Florida Retirement System
77
State Board of Administration of Florida Retirement System
Florida
$208K
PPA
78
Parametric Portfolio Associates
Washington
$205K -$135K -11,882 -32%
FRM
79
Fox Run Management
Connecticut
$181K +$252K +22,175 New
LSERS
80
Louisiana State Employees Retirement System
Louisiana
$178K +$15.9K +1,400 +7%
KeyBank National Association
81
KeyBank National Association
Ohio
$177K +$62K +5,464 +34%
Balyasny Asset Management
82
Balyasny Asset Management
Illinois
$162K -$9.33M -822,118 -98%
BNP Paribas Financial Markets
83
BNP Paribas Financial Markets
France
$157K -$62.5K -5,502 -22%
Barclays
84
Barclays
United Kingdom
$157K +$43.1K +3,794 +24%
PCM
85
Piermont Capital Management
Missouri
$156K -$12.1K -1,070 -5%
VOYA Investment Management
86
VOYA Investment Management
Georgia
$156K
MERSOM
87
Municipal Employees' Retirement System of Michigan
Michigan
$155K
MIM
88
MetLife Investment Management
New Jersey
$153K +$212K +18,716 New
GIA
89
Granite Investment Advisors
New Hampshire
$151K +$210K +18,500 New
HIM
90
Hutchens Investment Management
New Hampshire
$150K
TD Asset Management
91
TD Asset Management
Ontario, Canada
$149K
NIT
92
NumerixS Investment Technologies
British Columbia, Canada
$140K +$195K +17,200 New
UBS Group
93
UBS Group
Switzerland
$137K -$91.4K -8,047 -32%
EMG
94
Ellington Management Group
Connecticut
$128K +$178K +15,700 New
CCMH
95
Cornerstone Capital Management Holdings
New York
$125K +$5.8K +511 +3%
TI
96
Trexquant Investment
Connecticut
$118K +$44.4K +3,914 +37%
Teacher Retirement System of Texas
97
Teacher Retirement System of Texas
Texas
$113K +$158K +13,902 New
MLICM
98
Metropolitan Life Insurance Company (MetLife)
New York
$112K -$148K -13,006 -49%
VF
99
Virtu Financial
New York
$112K +$156K +13,720 New
MSA
100
Mason Street Advisors
Wisconsin
$107K +$4.52K +398 +3%

CYTK Hedge Fund Activity: Q4 2017 in Review

134 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q4 2017, worth a combined $315M — down 45% from $575M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new CYTK positions and 21 closed out — a net gain of 3 holders — while 43 added to existing stakes and 46 trimmed.

The largest buyer was BVF Inc, adding an estimated $50.9M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $40.3M sold.

  • 134 institutional investors held Cytokinetics (CYTK) as of Q4 2017, up from 132 in Q3 2017.
  • Funds reported $315M of Cytokinetics stock for Q4 2017, down 45% quarter-over-quarter.
  • 24 funds opened new Cytokinetics positions in Q4 2017 and 21 closed out, a net change of +3 holders.
  • The largest Cytokinetics buyer in Q4 2017 was BVF Inc, an estimated $50.9M added.
  • The largest Cytokinetics seller in Q4 2017 was Janus Henderson Group, an estimated $40.3M sold.

Based on aggregated 13F filings for Q4 2017.